Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
112 results about "Critical illness" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Critical illness. Critical illness means that the person is diagnosed with a life threatening illness and requires hospitalisation. Even though the critical illness is life threatening, with timely medical intervention and proper treatment, the illness can be cured or the progress can be kept in check.
System and method for enhancing the return of an asset accumulation product
A system and method for allowing an individual to accumulate wealth faster in the event of an adverse personal consequence, such as a death, a disabling accident or a critical illness. The system and method includes issuing an asset accumulation product and an insurance rider that guarantees an increase in the yield of the asset accumulation product upon the occurrence of an adverse personal event.
Owner:AMERICAL INTERNATIONAL GROUP INC
Method for highly sensitive quantitative detection of quantum dot fluorescence immunochromatographic assay
ActiveCN102520165ASensitive quantitative detection fastRealize detectionMaterial analysisCritical illnessLinear range
The invention discloses a method for highly sensitive quantitative detection of quantum dot fluorescence immunochromatographic assay. The method includes: building a fluorescence immunochromatographic assay test strip on the basis of optimizing the structure of the test strip and components by the aid of excellent fluorescent characteristics of quantum dots and by means of combining quantum dot fluorescence labeling technology and immunochromatographic assay; detecting fluorescence signal strength of a quantitative belt and a quality control belt by the aid of a fluorescence quantometer and correcting the fluorescence strength of the quantitative belt by the aid of the quality control belt after immunochromatographic assay of the test strip; and further quantitatively detecting analyte according to a standard curve obtained by the fluorescence quantometer. The method is simple, rapid, accurate, low in cost and quite high in sensitivity. Compared with a conventional colloidal gold immunochromatographic assay method, the method has the advantages of fine labeling stability, low non-specificity, high sensitivity, wide linear range and accuracy in quantization. The method is applicable to samples such as blood samples, urine samples, spittle, excrement and the like, and can be applied to detection of critical illness, poison, food safety and the like.
Owner:BEIJING KANGMEI TIANHONG BIOTECH
Critical illness monitoring, infusion controlling, diagnosis and treatment integrated system and control method thereof
InactiveCN101496923ARealize closed-loop feedback controlCatheterFlow monitorsLoop controlCritical illness
The invention discloses a critical care, transfusion control, and diagnosis and treatment integrated system and a control method thereof. The system comprises a transfusion device, a transfusion care base station, a central monitoring server and a medical PDA, wherein the transfusion care base station forms a transfusion scheme and performs open-loop control on the transfusion device by a wireless or wire mode, or adjusts transfusion parameters according to a corresponding closed-loop algorithm by monitoring and analyzing physiological parameters of patients during the transfusion execution, and performs closed-loop control on the transfusion device by the wireless or wire mode; the central monitoring server is connected with the transfusion care base station by the wireless or wire mode and monitors the operating state of the transfusion care base station; and the medical PDA is connected with the transfusion care base station and / or the central monitoring server by the wireless mode and is used for displaying transfusion condition and managing transfusion process. The system organically combines a treatment means (venous transfusion) and the effect of the treatment means (the monitoring of the physiological parameters) into one system, thereby realizing the closed-loop control of one or more transfusion devices, and improving medical quality and work efficiency of medical personnel.
Owner:SUN YAT SEN UNIV +1
Human body oxidative stress non-invasive fluorescence detection device and method
InactiveCN101716069AAvoid painAvoid the risk of infectionDiagnostic recording/measuringSensorsDiseaseBeam splitter
The invention discloses human body oxidative stress non-invasive fluorescence detection device and method. An excitation light source system comprises one near ultraviolet light source and one light filter and one beam splitter which are arranged on the emergent light path of near ultraviolet light source; wherein the beam splitter splits the emergent light into a reference light and an exciting light. A spectrum acquisition system comprises a conduction optical fiber, a fiber probe and a spectrometer. The conduction optical fiber is used for transmitting the reference light to the spectrometer; the fiber probe is used for transmitting the exciting light to skin part of human body to be tested, collecting fluorescent light generated by excitation on skin of human body and transmitting the fluorescent light to the spectrometer. The spectrometer is used for analyzing and processing the collected spectrum signal and finally obtains oxidative stress status of the detected object. Autofluorescence of skin is utilized to reflect human body oxidative stress status, detection speed is rapid, and result can be displayed in real time. The invention can provide reliable basis for prevention, diagnose and treatment effect evaluation on critical illness.
Owner:ANHUI INST OF OPTICS & FINE MECHANICS - CHINESE ACAD OF SCI
Therapeutic device for cancer diseases
ActiveCN101120904APrevent diffusion, transfer and restore functionUltrasound therapyMedical devicesEtiologyCancer prevention
Owner:李复生
Rehabilitation therapy determination method and device, storage medium and electronic equipment
PendingCN111105859AReal-time monitoring of target index parametersKnow your healthMedical communicationPhysical therapies and activitiesDiseaseCritical illness
The invention belongs to the technical field of computers, and relates to a rehabilitation therapy determination method and device, a computer readable storage medium and electronic equipment. The method comprises the following steps: acquiring a target index and an object identifier, and sending a parameter acquisition request carrying the object identifier; receiving a target index parameter corresponding to the target index based on the parameter acquisition request; inputting the target index parameter into a pre-trained machine learning model to enable the machine learning model to outputa target therapy; obtaining an evaluation standard corresponding to the target index, and if the target index parameter does not meet the evaluation standard, generating early warning information corresponding to the target therapy; and adjusting the target therapy according to the early warning information so as to carry out corresponding rehabilitation training. On one hand, medical staff monitor target index parameters of an object in real time and know the health condition of the object; on the other hand, accurate treatment measures and methods are recommended to medical staff, passive rescue is changed into active intervention treatment, and great influences are achieved on prevention against serious diseases.
Owner:TAIKANG LIFE INSURANCE CO LTD
Disease prediction method and device, medium, and electronic equipment
ActiveCN107658023AImprove health management levelDiscovered in timeMedical data miningHealth-index calculationCritical illnessCrowds
The embodiment of the invention provides a disease prediction method and device, a medium, and electronic equipment. The method comprises the steps: obtaining the data, correlated with health, of a plurality of users; carrying out the clustering analysis of the plurality of users based on the data, correlated with the health, of the users, so as to dividing the users into at least one class; determining a target class where a diagnosed patient belongs, and predicting other users in the target class as a high-risk group of diseases. According to the technical scheme of the invention, the methodcan achieve the prediction of the group which may have diseases, can guarantee the timely finding of severe diseases, so as to find and treat a disease early, and improve the level of health management of users.
Owner:TAIKANG LIFE INSURANCE CO LTD
Human health condition identification method based on BP neural network
InactiveCN106175726ARecognition results are simple and intuitiveScience of evaluation resultsSensorsPsychotechnic devicesDiseaseLife activity
The present invention relates to a method for identifying human health status based on BP neural network, comprising the following steps: S1, processing the actual measured values of physiological, psychological and behavioral indicators of people who do not suffer from major diseases to obtain the normalization of each indicator value; S2, BP neural network structure initialization; S3, BP neural network recognition training; S4, measure and test the human body to be recognized, and obtain the actual measured value of the selected human body index; S5, use the trained BP neural network to carry out Health status identification. The present invention effectively fuses multiple physiological, psychological, and behavioral index values that reflect the health status of the human body, and provides the health status identification results through the BP neural network model, which not only makes the identification results of the health status of the human body simpler and more intuitive, but also The evaluation results can enable non-professionals to clearly and clearly understand their own health status, and have important guiding significance for the adjustment of human-related life activities and even the prevention and treatment of diseases.
Owner:夏茂
Compositions and Methods for Treating Disease
InactiveUS20080206231A1Significant positive effectIncreasing IR-mediated ERK pathway activationPeptide/protein ingredientsAntibody ingredientsDiabetic heartDyslipidemia
The present invention discloses for the first time that the insulin receptor (IR) is a target of Herstatin, which modulates IR and IR-mediated intracellular signaling. In preferred aspects, Herstatin binds at nM concentrations to cell-surface IR, up-regulates basal IR expression by several-fold, induces the accumulation of pro-IR, and stimulates insulin activation of the ERK pathway. Moreover, these changes in insulin signaling are accompanied by alterations in IGF-IR expression, IRS-2 levels, and the serine phosphorylation state of both IRS-1 and IRS-2. Preferred aspects provide novel therapeutic methods and pharmaceutical compositions for treatment of conditions associated with altered IR expression or IR-mediated signaling, including but not limited to insulin resistance syndrome, pre-diabetic conditions, metabolic syndrome, type 1 and type 2 diabetes, cardiac disease, diabetes-associated vascular disease, atherosclerosis, hypertension, diabetes-associated lipid metabolism disorders (dyslipidemia), obesity, critical illness, neurodegenerative disorders, and combinations thereof, and cancer.
Owner:OREGON HEALTH & SCI UNIV
Equipment for treating cardiovascular and cerebrovascular diseases
ActiveCN101116761AReduce morbidityReduce mortalityRespiratorsChiropractic devicesCritical illnessExisting Treatment
The invention discloses a cardiovascular and cerebrovascular disease therapeutic apparatus capable of positioning function recovery therapy, preventing hypertension and cardiovascular and cerebrovascular diseases, and carrying out clinic therapy and first-aid, which consists of an oxygen inhalation horizontal exerciser and a massager and utilizes physical and chemical medicine combination treatment; the oxygen inhalation horizontal exerciser consists of a bed body, an oxygen inhalation device and a rotary wheel, for oxygen inhalation, respiratory administration, recovering abdominal breathing function and reducing blood pressure, which is combined with medicine oral administration, and the massager comprises medicine cloth and a massage head for medically massaging rigid muscle and activating blood, which is combined with local medicine injection; the invention is based on treatment principle and method of serious diseases, aims at the cause of hypertension and cardiovascular and cerebrovascular diseases to be function reduction and structural damage which are restricted by each other, and integrates function recovery with existing treatment of medicine, operation, and bypass grafting injury protection which can promote one another. The invention can cure cardiovascular and cerebrovascular diseases by treatment of disease cause.
Owner:李复生
1, 2, 3-triazole compound and application thereof in preparing indoleamine 2, 3-dioxygenase inhibitor
InactiveCN101786993APromote decompositionLow toxicitySenses disorderNervous disorderDiseaseTryptophan
The invention belongs to the field of pharmaceutical chemistry and relates to a 1, 2, 3-triazole compound, comprising 4-(2-bromophenyl)-1H-1, 2, 3-triazole and 4-(2-chlorphenyl)-1H-1, 2, 3-triazole. The result of an inhibitory activity test of indoleamine 2, 3-dioxygenase indicates that the disclosed 1, 2, 3-triazole compound used as the indoleamine 2, 3-dioxygenase inhibitor has broad prospect of application and can be applied to the treatment of diseases with indoleamine 2, 3-dioxygenase-mediated tryptophan metabolic pathway pathological characteristics, including cancer, AIDS (Acquired Immure Deficiency Syndrome), Alzheimer disease, tristimania, cataract and other critical diseases.
Owner:FUDAN UNIV
Beidou-based emergency helicopter navigation positioning system and navigation positioning method thereof
ActiveCN107064978APrecise positioningGood landing placeDiagnostic recording/measuringSensorsImaging processingCritical illness
The present invention discloses a Beidou-based emergency helicopter navigation positioning system and a navigation positioning method thereof. Based on the characteristics of the Beidou system, namely high-precision navigation and two-way short message communication, the landing site of an emergency helicopter can be quickly found out with the assistance of the GIS vector map technology and the image processing technology. Meanwhile, the functions of planning an optimal route, navigation, remote monitoring the life indexes of a patient and the like are realized. Based on the system and the method, the precious rescue time of gold is provided for the helicopter emergency operation on patients with critical illnesses and critically wounded patients during emergent events. Meanwhile, the conditions of patients can be known for the working personnel at hospital, so that the working personnel at hospital can prepare surgeries in advance. Therefore, the success rate of rescue is greatly improved.
Owner:SOUTHEAST UNIV
Method for preparing digestion-free protein from active protein as raw material
The invention discloses a digestion-free protein product with placenta activity. The product is obtained as follows: fertilized eggs are hatched, a living embryo is used as a protein material (containing small live fish), and disinfection, shelling, crushing, blending, sterilization, ultra-long-time enzymolysis and separation for removal of insoluble matter are performed. The product is formed bycompound amino acid with dipeptide and tripeptide molecular weight between 300 DA and 500 DA and the average molecular weight being 125 DA. Science proves that only the part is digestion-free proteinand can be directly absorbed and utilized by the human body through small intestines. No digestion-free protein products are found on the market at present. The product has the benefits as follows: the digestion-free protein product is provided for old people and people with poor digestion functions, and protein balance can be kept. Three health revolutions including vaccination for smallpox, treatment of diseases caused by viruses and bacteria with penicillin and treatment with small-molecular active peptide exist in the human history. The root cause of all critical diseases is the cell faultproblem.
Owner:CHANGCHUN UNIV
Device for predicting critical illness of COVID-19 patient
ActiveCN112102945AAccurate predictionImprove accuracyMathematical modelsHealth-index calculationCritical illnessHematological test
The invention discloses a device for predicting the critical illness of a COVID19 patient, and belongs to the intelligent processing technology of medical data. The system comprises an input module used for inputting patient information; the data preprocessing module is used for carrying out data preprocessing on the data output by the input module, sending a processing result to the feature selection module if the data is training data, and sending the processing result to the prediction processing module if the data is to-be-predicted data; the feature selection module is used for selectinga certain number of features from the input features as input feature selection results; and the prediction processing module is used for inputting the characteristic information of the patient into apreset prediction model and sending a prediction result to the prediction result output module for visual output. According to the method, key features are selected from the blood detection result ofthe patient so as to guarantee the prediction accuracy of the critical illness of the COVED19 patient, medical assistance for quickly shunting the patient suffering from the COVED19 is achieved, medical resources can be optimized, and medical intervention can be conducted in time.
Owner:UNIV OF ELECTRONIC SCI & TECH OF CHINA
Smart bracelet and APP platform remote processing method
The invention provides a smart bracelet and an APP platform remote processing method and belongs to the technical fields of smart bracelets and family doctors. The method comprises a doorbell calling step, a tumbling alarm step, a disease calling step, a step of connection with a downloaded app, a health monitoring step, a one-key dialing step, a medical history and basic patient information inputting step, a voice communication step, a positioning step, a step of displaying of previous medication situations, diagnosis hospitals, surrounding hospital information and departments, a 120 one-key calling step, a one-key family calling step and a body index anomaly monitoring step. The smart bracelet has the advantages as follows: the smart bracelet is targeted at the old people who have no company of children in life or people suffering from serious diseases, so that people can monitor the body conditions and emergencies by wearing the bracelet, and the function of providing aids immediately is realized. The smart bracelet can monitor the body conditions, has a calling function of a smart watch, provides promptest aids for patients and performs monitoring in daily life.
Owner:边宝骏
Stepwise multivariable regression model for predicting diseased survival time and application thereof
InactiveCN106202988AImproving Survival Prediction AccuracyImprove accuracyMedical data miningMedical automated diagnosisDiseaseReal variable
Owner:HARBIN INST OF TECH SHENZHEN GRADUATE SCHOOL
Digital disease control information integration and intelligent public health management platform
InactiveCN103544568ARealize whole-process data monitoringAccurate massResourcesCritical illnessDisease surveillance
A digital disease control information integration and intelligent public health management platform comprises a management platform server, a database server, an OA office system, a disease surveillance system, an inspection report system, a medical information system, a child preventive vaccination management system, an internal network, an external network, a child preventive vaccination outpatient department, a disease surveillance terminal, a health hazard factor monitoring terminal, a serious disease special reporting system, a public health emergency commanding system, an expert system, a medical information workstation, a monitoring terminal, a testing laboratory, a subordinate unit system, a superior unit system and an information searching and publishing system. All disease data collection and the whole data monitoring of diseases are achieved, and data samples can cover all people and the whole periods of the diseases. Dynamic quality control management is achieved, and therefore management quality and the accuracy of the data are guaranteed, quality control cost and administrative management cost are lowered, and disease prevention and management efficiency is improved.
Owner:济南市疾病预防控制中心
Preparation method of tryptanthrin compound and new application of tryptanthrin compound in preparing indoleamine-2,3-dioxygenase (IDO) inhibitor
Owner:SHENYANG XINMA PHARMA
Gold nano-rod and up-conversion nano-crystal composite nano-material as well as preparation method thereof
InactiveCN107418554AImprove protectionImprove thermal stabilityPowder deliveryMaterial nanotechnologyCritical illnessPolyethylene glycol
The invention discloses a gold nano-rod and up-conversion nano-crystal composite nano-material as well as a preparation method thereof. The composite nano-material is characterized in that a gold nano-rod is a core layer, silicon dioxide is an isolating layer and an up-conversion nano-crystal is a shell layer; the gold nano-rod is prepared by firstly using a seed method, cetyltrimethyl ammonium bromide (CTAB) on a surface of the gold nano-rod is replaced with methoxy polyethylene glycol (mPEG) to obtain the gold nano-rod of which the surface is coupled with mPEG; under a slightly alkaline condition, tetraethylorthosilicate (TEOS) is hydrolyzed to obtain a gold nano-rod composite structure covered with silicon dioxide, an up-conversion nano-crystal shell layer doped with rare earth is obtained through a urea hydrolysis method, and finally, an AuNR / SiO2 / Y2O3:Yb,Er composite nano-structure is formed. A sample prepared by the invention has multiple functions of photothermal conversion and fluorescence labeling, the problem that the up-conversion nano-crystal doped with the rare earth is difficultly grown on the surface of the gold-nano rod covered with the silicon dioxide in the prior art is solved, and the sample is potentially applied to the fields of early diagnosis and treatment on serious illness such as cancers.
Owner:LUOYANG INST OF SCI & TECH
Biosensor for detecting Hg<2+> and preparation method thereof
The invention provides a biosensor for detecting Hg<2+> and a preparation method thereof, which can be used in the fields of environmental monitoring, medical treatment and public health, food safety, life sciences and the like. According to the biosensor, a gold nanocage is combined with a Hg<2+> recognition probe by utilizing a surface positive charge modification technique and electrostatic interaction, so that a nanocarrier with a molecular biological door is constructed, and a single-stranded DNA molecular door which is rich in T basic groups is opened through specific molecular recognition reaction, so that fluorescent molecules are released, and the detection of fluorescent signals is realized. Therefore, by utilizing the biosensor, the high-sensitivity and high-selectivity detection of Hg<2+> can be realized. Additionally, on the basis of a controlled release technique of guest molecules in the nanocarrier of the biosensor, a new way and method is provided for the delivery of tumor targeted drugs and the clinical diagnosis and treatment of serious diseases.
Owner:云南通标检测有限公司
Two-dimensional nanocomposite, preparation method therefor and application of two-dimensional nanocomposite
PendingCN111084882ATo achieve the purpose of integration of diagnosis and treatmentTo achieve the effect of full spectrum absorptionMaterial analysis using wave/particle radiationEnergy modified materialsOxygen vacancyCritical illness
The invention discloses a nanocomposite. The nanocomposite comprises black BiOX particles and an envelopment, wherein the envelopment is a biological compatible material; a photothermal conversion efficiency of the nanocomposite is not lower than 10%; and BiOX is at least one selected from BiOF, BiOCl, BiOBr, BiOI and BiOAt. The invention further discloses a preparation method for the nanocomposite and application of the nanocomposite. The nanocomposite is a two-dimensional black bismuth oxyhalide nano-material with an oxygen vacancy defect and is applied to photothermal therapy of tumors, andthus, a photothermal conversion material with wide absorption spectrum, high photothermal conversion efficiency and high molar extinction coefficient can be obtained; and by applying the nanocomposite to integration of diagnosis and treatment of the tumors, a diagnosis and treatment integrated reagent with good treatment effect and remarkable and excellent CT imaging performance can be obtained,identification and checkout on the tumors and serious diseases of heart and cerebral vessels, nervous systems, skeleton muscles and the like can be improved, and functions such as follow-up treatment,treatment effect following and prognosis evaluation during tumor treatment can also be achieved.
Owner:CIXI INST OF BIOMEDICAL ENG NINGBO INST OF MATERIALS TECH & ENG CHINESE ACAD OF SCI +1
Parametric draw-down system for risk sharing of critical illness risks and corresponding method thereof
InactiveUS20150112734A1Improve system stabilityImprove stabilityFinanceHealth-index calculationRisk sharingRisk exposure
Proposed are a parametric, event-driven critical illness insurance system based on a resource-pooling system (1) and method for risk sharing of critical illness risks of a variable number of risk exposure components (21, 22, 23) by providing a dynamic self-sufficient risk protection for the risk exposure components (21, 22, 23) by means of the resource-pooling system (1). The resource-pooling system (1) comprises an assembly module (5) to process risk-related component data (211,221,231) and to provide the likelihood (212, 222, 232) of said risk exposure for one or a plurality of the pooled risk exposure components (21, 22, 23, . . . ) based on the risk-related component data (211, 221, 231). The risk exposure components (21,22,23) are connected to the resource-pooling system (1) for the pooling of their risks and resources, and wherein the resource-pooling system (1) comprises an event-driven core-engine (3) with critical illness triggers (31, 32, 33) triggering in a patient dataflow pathway (213,223,233) to provide risk protection for a specific risk exposure component (21,22,23). The operation of the resource pooling system (1) is supported by a parametric draw-down risk-cover which can additionally be related to multiple occurrences of critical illness parameters 71,72,73 triggered in the related patient data flow pathway (213, 223, 233).
Owner:SWISS REINSURANCE CO LTD
Parametric system for risk sharing of critical illness risks and corresponding method thereof
ActiveUS20150112735A1Improve system stabilityImprove stabilityFinanceHealth-index calculationRisk exposureResource pool
Proposed are a parametric, event-driven critical illness insurance system based on a resource-pooling system (1) and method for risk sharing of critical illness risks of a variable number of risk exposure components (21, 22, 23) by providing a dynamic self-sufficient risk protection for the risk exposure components (21, 22, 23) by means of the resource-pooling system (1). The resource-pooling system (1) comprises an assembly module (5) to process risk-related component data (211,221,231) and to provide the likelihood (212, 222, 232) of said risk exposure for one or a plurality of the pooled risk exposure components (21, 22, 23, . . . ) based on the risk-related component data (211, 221, 231). The risk exposure components (21,22,23) are connected to the resource-pooling system (1) for the pooling of their risks and resources, and wherein the resource-pooling system (1) comprises an multiple event-driven core-engine (3) with critical illness triggers (31, 32, 33) triggering in a patient dataflow pathway (213,223,233) to provide risk protection for a specific risk exposure component (21,22,23). The operation of the resource pooling system (1) is further supported by a parametric risk-cover related to multiple occurrences of critical illness parameters 71,72,73 triggered in the related patient data flow pathway (213, 223, 233).
Owner:SWISS REINSURANCE CO LTD
Rapid detection kit for myocardial infarction
InactiveCN104714031AQuick exclusionExclude earlyDisease diagnosisBiological testingDiseaseCritical illness
The invention discloses a rapid detection kit for myocardial infarction. The kit comprises a cardiac troponin I (cTnI) detection reagent, a cardiac troponin T (cTnT) detection reagent and a heart-type fatty acid-binding protein (H-FABP) detection reagent. According to the rapid detection kit disclosed by the invention, three indexes are simultaneously used and are integrated together to prepare the kit, and the kit is convenient to carry and simple in detection process; by simultaneously rapidly detecting cTnI, cTnT and H-FABP, AMI can be diagnosed or eliminated within 1 hour after disease attack, disease attack stages can be determined, the critical illness degree can be evaluated, and the advantages of bedside and on-site rapid applications can be achieved; AMI can be confirmed or eliminated in a very early stage, risk stratification can be achieved, and the purpose of monitoring AMI in the whole course can be achieved; and by virtue of triple detection, a maximum detection time window of AMI can be provided, and high sensitivity and relatively strong specificity (avoiding false positive) can also be achieved.
Owner:王义明
Online-internal-extraction electrospray-ionization mass-spectroscopy detection device for rapidly analyzing body fluid samples of human body
PendingCN106645374ALow costEasy to manufacturePreparing sample for investigationMaterial analysis by electric/magnetic meansCritical illnessSpectrograph
The invention relates to an online-internal-extraction electrospray-ionization mass-spectroscopy detection device for rapidly analyzing body fluid samples of a human body, and belongs to the technical field of chemical analysis. The detection device consists of an eluate introduction device, an in-situ sample enriching extractor, a sample introduction device, an electrospray ionization source and a mass spectrograph, wherein the eluate introduction device is used for introducing a flowing phase for sample eluting, the in-situ sample enriching extractor is used for carrying out sample loading and online extracting and enriching, the sample introduction device is used for introducing eluted samples into the electrospray ionization source for electrospraying, and the mass spectrograph is used for carrying out detection and analysis on online samples, so as to obtain mass-spectroscopy molecular fingerprint spectrogram information on the samples. According to the detection device, the detected human body fluid samples may be human body fluids such as blood, urine, sweat and saliva, do not need sample pretreatment, and are subjected to in-situ sample loading. The device provided by the invention is simple in structure and low-cost, the practicability is high, the detection time and economic cost are reduced greatly, and a technical support is provided for the rapid diagnosis and screening of critical illnesses.
Owner:JILIN UNIV
Two-dimensional nano composite material as well as preparation method and application thereof
ActiveCN111388666ATo achieve the purpose of integration of diagnosis and treatmentTo achieve the effect of full spectrum absorptionPowder deliveryMaterial nanotechnologyIsobenzofuranCritical illness
The invention discloses a nano composite material which comprises BiOX particles and a coating, wherein the BiOX particles have oxygen vacancy defects; and the coating is a biocompatible material. under near-infrared radiation, the photothermal conversion efficiency of the nano composite material is greater than or equal to 10%; under near-infrared radiation, the velocity that 1,3-diphenyl isobenzofuran is degraded by the nano composite material is greater than or equal to 0.1mmol / h; and BiOX is selected from at least one of BiOF, BiOCl, BiOBr, BiOI and BiOAt. The invention further discloses apreparation method and application of the nano composite material. The nano composite material is a bismuth oxyhalides nano material with oxygen vacancy defects at different concentrations, and is applied to photothermal treatment on tumors; and the nano composite material is applied to integration of diagnosis and treatment on tumors, and is a diagnosis and treatment integral reagent which is good in treatment effect and excellent in CT (computed tomography) imaging and photoacoustic imaging performance, distinguishing and detection on critical illnesses such as tumors can be improved, and functions of follow-up treatment, treatment effect tracking, prognosis evaluation, and the like, can be achieved.
Owner:CIXI INST OF BIOMEDICAL ENG NINGBO INST OF MATERIALS TECH & ENG CHINESE ACAD OF SCI +1
Biomarkers for early determination of a critical or life threatening response to illness and/or treatment response
InactiveUS20140179806A1Unnecessary administrationBiocideMicrobiological testing/measurementDiseaseCritical illness
The invention relates to the use of novel biomarkers and biomarker combinations having utility in the early determination of an individual's critical and / or life threatening response to illness and / or in predicting outcome of said illness. The measurement of expression levels of the products of the biomarkers and combinations of biomarkers of the invention have utility in making the determination of an individual's critical and / or life threatening response to illness. In some embodiments, the biomarker and biomarker combinations are agnostic and are independent of the pre-identification and / or determination of the cause or nature of the illness. In some embodiments, the biomarkers and biomarker combinations can be utilized to select treatment and / or monitor the effectiveness of treatment interventions for an individual who has a critical illness.
Owner:FIO CORP
Early warning system based on independent risk factor combinatory screening
InactiveCN105232060AReduce morbidityReduce mortalityDiagnostic recording/measuringSensorsBlood test resultEarly warning system
The invention discloses an early warning system based on independent risk factor combinatory screening. In the system, an input module of the system is used for inputting personal basic information of a user to be detected, a selector module is used by the user to be detected, to select a blood test scheme to be carried out, a blood sampling device is used for collecting blood of the user to be detected, a blood tester is used for detecting type of the chosen blood test scheme for the collected blood of the user to be detected, a data processing module is used for receiving blood test results transmitted by the blood tester, comparing the blood test results with pre-stored reference data, and transmitting comparison results and conclusions to a results processing module after comparison is complete, and the results processing module is used for processing the received comparison results and conclusions, and transmitting the processed results to a results output module for displaying. The system and method carry out detection in a most convenient and feasible manner, attack rate of serious diseases and death rate are decreased, and the cost is low.
Owner:陈琼
Homogeneous phase multi-index fluorescence/chemiluminescence measuring method and application thereof
InactiveCN101995396ALess serumShort detection timeChemiluminescene/bioluminescenceFluorescence/phosphorescenceCritical illnessFluorescence
The invention belongs to the field of blood testing, and relates to a homogeneous phase multi-index fluorescence / chemiluminescence measuring method and application thereof. The method comprises the steps of: fixing a plurality of specificity recognition monoclonal antibodies on a polystyrene microsphere, and reacting with a plurality of labeled antibody cores modified by haptens after combining with carcinoembryonic antigens, cell keratin fragments 19, neuron specificity enolase and other multiple markers; reacting with horse radish peroxidase modified by corresponding hapten antibodies, alkaline phosphatase and quantum dots, and measuring a plurality of markers on the same instrument by combining with detections of chemiluminescence, fluorescence and the like. The method has the advantages of small blood serum consumption, rapid detection time, low diagnosis cost and simple operation, is suitable for detecting a plurality of popularized indexes simultaneously, and can provide auxiliary judgment basis for the early diagnosis of critical illnesses of tumor and the like.
Owner:FUDAN UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com